3078 Updated results and efficacy analysis according to epidermal growth factor receptor (EGFR) mutation subtypes and metastatic sites for the phase II trial of gefitinib in combination with carboplatin plus S1. (September 2015)

Record Type:: Journal Article
Title:: 3078 Updated results and efficacy analysis according to epidermal growth factor receptor (EGFR) mutation subtypes and metastatic sites for the phase II trial of gefitinib in combination with carboplatin plus S1. (September 2015)
Main Title:: 3078 Updated results and efficacy analysis according to epidermal growth factor receptor (EGFR) mutation subtypes and metastatic sites for the phase II trial of gefitinib in combination with carboplatin plus S1
Authors:: Tamiya, A.
Tamiya, M.
Shiroyama, T.
Tsuji, T.
Morishita, N.
Omachi, N.
Okamoto, N.
Hidekazu, S.
Okishio, K.
Hirashima, T.
Atagi, S.
Abstract:
Is Part Of:: European journal of cancer. Volume 51:(2015)Supplement 3
Journal:: European journal of cancer
Issue:: Volume 51:(2015)Supplement 3
Issue Display:: Volume 51, Issue 3 (2015)
Year:: 2015
Volume:: 51
Issue:: 3
Issue Sort Value:: 2015-0051-0003-0000
Page Start:: S623
Page End:
Publication Date:: 2015-09
Subjects:: Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:: http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0959-8049(16)31719-1 ↗
Languages:: English
ISSNs:: 0959-8049
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 2034.xml